spacer

CDC Home > HIV/AIDS > Topics > Pregnancy and Childbirth
space Pregnancy and Childbirth
space
arrow Prevention Challenges
space
arrow What CDC is Doing
space
arrow Developing a Prevention Program
space
arrow Resources
space
arrow Grantees Meetings
space
arrow One Test. Two Lives
space
arrow Links
space
arrow Bibliography
space
arrow What Women Can Do
space
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Bibliography
spacer
spacer
  1. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Human immunodeficiency virus screening. Pediatrics 1999;104(1):128.
  2. American College of Obstetricians and Gynecologists, Committee on Obstetrical Practice. Committee opinion: scheduled cesarean section delivery and the prevention of vertical transmission of HIV infection. ACOG Comm Opin 2000;234:l-3.
  3. Anderson JE, Koenig LJ, Lampe MA, Wright R, Leiss J, Saul J. Achieving universal HIV screening in prenatal care in the United States: provider persistence pays off. AIDS Patient Care STDs. 2005;19(4):247-52.
  4. Bertolli J, St Louis ME, Simonds RJ, Nieburg P, Kamenga M, Brown C, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis. 1996 Oct;174(4):722-6.
  5. Branson B. Rapid tests for HIV antibody. AIDS Review 2000;2:76-83.
  6. Bulterys M, Jamieson DJ, O'Sullivan MJ, Cohen MH, Maupin R, Nesheim S, Webber MP, Van Dyke R, Wiener J, Branson BM. Rapid HIV-1 testing during labor:  A multicenter study. JAMA 2004;292(2):219-223.
  7. Bulterys M, Nolan M, Jamieson D, Dominguez K, Fowler MG. Advances in the prevention of mother-to-child HIV-1 transmission: current issues, future challenges.Non-CDC Web Link AIDScience 2002;2(4).
  8. Bulterys M, Fowler MG. Prevention of HIV infection in children. Pediatr Clin North Am 2000;47:21-38.
  9. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Atlanta: US Department of Health and Human Services 2006, revised 2007.
  10. Centers for Disease Control and Prevention. HIV/AIDS Surveillance in Women (through 2005). Atlanta, GA: Divisions of HIV/AIDS Prevention, Centers for Disease Control and Prevention; 2007.
  11. Centers for Disease Control and Prevention. Pediatric HIV/AIDS Surveillance (through 2005). Atlanta, GA: Divisions of HIV/AIDS Prevention, Centers for Disease Control and Prevention; 2007.
  12. Centers for Disease Control and Prevention. Achievements in public health: Reduction in perinatal transmission of HIV infection, United States, 1985—2005. MMWR 2006;55(21):592-7.
  13. Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing of Adults, Adolescents, And Pregnant Women in Health Care Settings. MMWR. 2006;55(RR-14);1-17.
  14. Centers for Disease Control and Prevention. Dear Colleague Letter.PDF Icon 2005.
  15. Centers for Disease Control and Prevention. Enhanced Perinatal HIV/AIDS Surveillance, United States, 1999-2001, Special Surveillance Report No. 4. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
  16. Centers for Disease Control and Prevention. Rapid Point-of-Care Testing for HIV-1 During Labor and Delivery --- Chicago, Illinois, 2002. MMWR 2003;52(36):866-868.
  17. Centers for Disease Control and Prevention. Dear Colleague Letter. April 22, 2003.
  18. Centers for Disease Control and Prevention.  HIV Testing Among Pregnant Women --- United States and Canada, 1998--2001. MMWR 2002;51(45):1013-1016.
  19. Centers for Disease Control and Prevention. Successful Implementation of Perinatal HIV Prevention Guidelines: a Multistate Surveillance Evaluation. MMWR 2001:50(RR06);17-28.
  20. Centers for Disease Control and Prevention. Prenatal discussion of HIV testing and maternal HIV testing-14 States, 1996-1997. MMWR 1999;48(19):401-404.
  21. Chou R, Smits AK, Huffman LH, Fu R, Korthuis PT. Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2005;143:38-54.
  22. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331(18):1173-80.
  23. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29(5):484-94.
  24. Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, et al. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis. 1994 Nov;170(5):1134-40.
  25. Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL; International PACTG 316 Team. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002;288(2):189-98.
  26. Fernandez MI, Wilson TE, Ethier KA, Walter EB, Gay CL, Moore J. Acceptance of HIV testing during prenatal care. Public Health Rep 2000;115:460-468.
  27. Fleming P, Lindegren M, Byers R, Hammett T, Harris N, Schulte J, et al. Abstract no. TuPeC477: Estimated number of perinatal HIV infections, U.S., 2000.  14th International AIDS Conference. Barcelona, Spain; 2002.
  28. Forsyth BW, Barringer SR, Walls TA, Landry ML, Ferguson D, Tinghitella TJ, Unfricht M, Luchansky E, Magriples U. Rapid HIV testing of women in labor: too long a delay. J Acquir Immune Defic Syndr 2004;35(2):151-4.
  29. Fowler MG, Simonds RJ, Roongpisuthipong A. Update on perinatal HIV transmission. Pediatr Clin North Am 2000;47:21-38.
  30. Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan ME. Preventing perinatal transmission of HIV- costs and effectiveness of a recommended intervention. Public Health Rep 1996;111(4):335-341.
  31. Graves N, Walker DG, McDonald AM, Kaldor JM, Ziegler JB. Would Universal Antenatal Screening for HIV Infection Be Cost-Effective in a Setting of Very Low Prevalence? Modelling the Data for Australia. J Infect Dis 2004;190(1):166-74.
  32. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005 Oct 1;366(9492):1182-8.
  33. Grobman W, Garcia P. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. Am J Obstet Gynecol 1999;181(5):1062-1071.
  34. Immergluck L, Cull W, Schwartz A, Elstein A. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago. Pediatrics 2000;105(4):54-63.
  35. Institute of Medicine, Committee on Perinatal Transmission of HIV and Commission on Behavioural and Social Sciences and Education. Reducing the odds: preventing perinatal transmission of HIV in the United States.Non-CDC Web Link National Academy Press, 1999, Washington, DC.
  36. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999;340(13):977-987.
  37. Jamieson DJ, O’Sullivan MJ, Maupin R, Cohen M, Webber MP, Nesheim S, Lampe M, Garcia P, Lindsay M, Bulterys M. The challenges of informed consent for rapid HIV testing in labor. Journal of Women's Health 2003;12:889-95.
  38. Lansky A, Jones JL, Frey RL, Lindegren ML. Trends in HIV testing among pregnant women in the United States, 1994-1997. American Journal of Public Health 2001;91:1291-1293.
  39. Lazzarini Z, Rosales, L. Legal issues concerning public health efforts to reduce perinatal HIV transmission. Yale Journal of Health Policy, Law, and Ethics 2002;3(1):67-98.
  40. Lindau ST, Jerome J, Miller K, Monk E, Garcia P, Cohen M. Mothers on the margins: implications for eradicating perinatal HIV. Soc Sci Med. 2006 Jan;62(1):59-69.
  41. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999;282:531-38.
  42. Lindegren ML, Steinberg S, Byers RH. Epidemiology of HIV/AIDS in children. Pediatr Clin North Am 2000;47: l-20.
  43. de Martino M, Tovo PA, Tozzi AE, Pezzotti P, Galli L, Livadiotti S, et al. HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS. 1992 Sep;6(9):991-7.
  44. McKenna M, Hu X. Recent trends in the incidence and morbidity associated with perinatal human immunodeficiency virus infection in the United States. American Journal of Obstetrics and Gynecology. 2007;197(3 Suppl 1):S10-S16.
  45. Minkoff H, O’Sullivan, M. The case for rapid HIV testing during labor [editorial]. JAMA 1998;279:1743-4.
  46. Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 2000;355(9222):2237-44.
  47. Mrus JM, Tsevat J. Cost Effectiveness of Interventions to Reduce Vertical HIV Transmission from Pregnant Women Who Have Not Received Prenatal Care. Medical Decision Making 2004;24(1):30-39.
  48. Office of Inspector General, Health and Human Services. Reducing obstetrician barriers to offering HIV testing. OEI-05-01-00260. Washington, DC: Department of Health and Human Services, March 2002.
  49. Orloff, SL, Bulterys M, Vink P, Nesheim S, Abrams EJ, Schoenbaum E, Palumbo P, Steketee RW, Simonds RJ, and the Perinatal AIDS Collaborative Transmission Study (PACTS). Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four U.S. cities, 1994-1998. Journal of Acquired Immune Deficiency Syndromes 2001;28:65-72.
  50. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States - Living Document. Last update: October 12, 2006. Updated guidelines available online.
  51. Pulver WP, Glebatis D, Wade N, Birkhead GS, Smith P. Trends from an HIV seroprevalence study among childbearing women in New York State from 1988 through 2000: a valuable epidemiologic tool. Arch Pediatr Adolesc Med 2004;158(5):443-8. 
  52. Respess R, Rayfield M, Donderro T. Laboratory testing and rapid HIV assays: implications for surveillance applications in hard-to-reach populations. AIDS 2001;15(suppl 3):S49-S59.
  53. Royce RA, Walter EB, Fernandez MI, Wilson TE, Ickovics JR, Simonds RJ, for the Perinatal Guidelines Evaluation Project. Barriers to universal prenatal HIV testing in 4 U.S. locations in 1997. American Journal of Public Health 2001;91:727-733.
  54. Sansom SL, Jamieson DJ, Farnham PG, Bulterys M, Fowler MG. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission. Obstet Gynecol 2003;102(4):782-90.
  55. Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K, Noga H, Craig AS, Thomson Sanza L, Smith G, Schuchat A. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 2003;102(4):753-60.
  56. Wade NA, Zielinski MA, Butsashvili M, McNutt LA, Warren BL, Glaros R, Cheku B, Pulver W, Pass K, Fox K, Novello AC, Birkhead GS. Decline in Perinatal HIV Transmission in New York State (1997-2000). J Acquir Immune Defic Syndr. 2004;36(5):1075-1082.
  57. Walter EB, Royce R, Fernandez MI, DeHovitz J, Ickovics J, Lampe M, for the Perinatal Guidelines Evaluation Project Group. New mothers’ knowledge and attitudes about perinatal human immunodeficiency virus infection. Obstetrics and Gynecology 2001;26:495-500.
  58. Warren B, Glaros R, Hackel S, et al. Residual perinatal HIV transmissions in 25 births occurring in New York State. 2005 National HIV Prevention Conference. Atlanta, GA; 2005.
  59. Watts DH. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med 2002;346(24):1879-91.
  60. Webber M, Demas P, Enriquez E, Shanker R, Oleszko W, Beatrice S, Schoenbaum E. Pilot study of expedited HIV-1 testing of women in labor at an inner-city hospital in New York City. American Journal of Perinatology 2001;18(1):49-57.
  61. Wilson T, Ickovics JR, Fernandez MI, Koenig LJ, Walter E. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four states. American Journal of Obstetrics and Gynecology 2001;184:1235-1240.
  62. Zaric G, Bayoumi AM, Brandeau ML, Owens DK. The cost-effectiveness of voluntary prenatal and routine newborn HIV screening in the United States. J Acquir Immune Defic Syndr 2000;25(5):403-416.
spacer
Last Modified: October 10, 2007
Last Reviewed: October 10, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov		 spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services